Search Result "ErbB2/HER2"
Peptides for Dual Targeting of ErbB1 and ErbB2: Blocking EGFR CellSignaling Transduction Pathways for Cancer Chemotherapy
Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-11
Author(s): Sunil Kumar Patnaik,Akey Krishna Swaroop,Moola Joghee Nanjan,Moola Joghee Nanjan Chandrasekar
Targeting of ErbB1, ErbB2, and their Dual Targeting Using Small Moleculesand Natural Peptides: Blocking EGFR Cell Signaling Pathways inCancer: A Mini-Review
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22 Issue: 22 Year: 2022 Page: 2831-2846
Author(s): Sunil Kumar Patnaik,Akey Krishna Swaroop
A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 15 Issue: 8 Year: 2015 Page: 665-683
Author(s): OtÃlia Menyhart,Libero Santarpia,Balazs Gyorffy
ADAM10 as a Target for Anti-Cancer Therapy
Journal: Current Pharmaceutical Biotechnology
Volume: 9 Issue: 1 Year: 2008 Page: 2-8
Author(s): Marcia L. Moss, Alexander Stoeck, Wenbo Yan, Peter J. Dempsey
Targeting ErbB Receptors in High-Grade Glioma
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 2468-2487
Author(s): Sabina Berezowska, Jurgen Schlegel
Development of EGFR Family Small Molecule Inhibitors for Anticancer Intervention: An Overview of Approved Drugs and Clinical Candidates
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 38 Year: 2014 Page: 4374-4404
Author(s): Weiyan Cheng,Yongzhou Hu,Rong Sheng
Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 14 Issue: 9 Year: 2014 Page: 775-793
Author(s): Deepa Subramaniam,Aiwu R. He,Jimmy Hwang,John Deeken,Michael Pishvaian,Marion L. Hartley,John L. Marshall
Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) andtheir Role in the Treatment of Cancer: A Review
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 20 Year: 2022 Page: 3370-3381
Author(s): Ananda Kumar Chettupalli,Mohammad Amjad Kamal
An Update on the Systemic Therapy of Malignant Salivary Gland Cancers: Role of Chemotherapy and Molecular Targeted Agents
Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 4 Issue: 6 Year: 2004 Page: 543-551
Author(s): M. Agulnik, L. L. Siu
Clinical Pharmacogenetics in Oncology: the Paradigm of Molecular Targeted Therapies
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 2 Year: 2010 Page: 2184-2193
Author(s): Giannis Mountzios, Despina Sanoudou, Konstantinos N. Syrigos